Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
MSF Access Campaign “We are seriously concerned with Gilead’s current approach to remdesivir, which may obscure access to this potentially critical treatment for #COVID19”Read our letter to @GileadSciences 👇 bit.ly/2QVeK4E 21:30 - 30 Mar 2020